SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
July 1, 2014
Date of Report
(Date of Earliest Event Reported)
LIGHTSTONE TECHNOLOGIES INC.
(Exact Name of Registrant as Specified in its Charter)
QUINCE RUN ACQUISITION CORPORATION
(Former Name of Registrant as Specified in its Charter)
Delaware 000-55063 46-3590822
(State or other
jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
Brudersweg 1,
57072 Siegen, Germany
(Address of Principal Executive Offices)
215 Apolena Avenue
Newport Beach, California 92662
(Former Address of Principal Executive Offices)
+49 176 76 409 251
(Registrant's Telephone Number)
ITEM 3.02 Unregistered Sales of Equity Securities
On July 2, 2014, Lightstone Technologies Inc. (formerly Quince Run
Acquisition Corporation) (the "Registrant" or the "Company") issued
1,000,000 shares of its common stock pursuant to Section 4(2) of the
Securities Act of 1933 at par representing 66.7% of the total outstanding
1,500,000 shares of common stock to Dr. Sergio Calqueiro.
With the issuance of the 1,000,000 shares of stock and the redemption
of 19,500,000 shares of stock (discussed below), the Company effected a change
in its control and the shareholder(s) elected new management of the Company.
The Company may develop its business plan by future acquisitions or mergers
but no agreements have been reached regarding any acquisition or other business
combination. The Company changed its name as part of the change in control.
If the Company makes any acquisitions, mergers or other business combination,
the Company will file a Form 8-K but until such time the Company remains a
shell company.
ITEM 5.01 Changes in Control of Registrant
On July 1, 2014, the following events occurred which resulted in a change
of control of the Registrant:
1. The Registrant redeemed an aggregate of 19,500,000 of the then
20,000,000 shares of outstanding stock at a redemption price of $.0001 per
share for an aggregate redemption price of $1,950.
2. The then current officers and directors resigned.
3. New officer(s) and director(s) were appointed and elected.
The disclosure required by Item 5.01(a)(8) of Form 8-K was previously
filed with the Securities and Exchange Commission on Form 10-12G filed on
September 30, 2013 as amended and supplemented by the information contained
in this report.
The Registrant anticipates that it will develop its business with a
combination with a private company or through the development of its business
plan. The Company anticipates that it will merge with an existing private
company that has three German subsidiaries developing applications for a
certain patented form of nuclear fusion the LENR technology). The LENR
technology has the capacity to produce large amounts of cheap and clean
electricity. The Company has built two prototype systems which produce
electricity on demand. Other applications of the technology include the
capacity to treat nuclear waste and reduce its half-life. The system takes
nuclear waste, treats it and turns it into 100% uranium. The technology has
also been applied to create a non-stick paint that is a paint to which nothing
will adhere. Such a paint, for instance, could be used on ship bottoms to
avoid marine growth on the hull, hospitals to reduce or eliminate adherence
of bacteria to walls or other surfaces, and buildings to eliminate graffiti.
The Company has not entered into any agreements or contracts and when and if
it does so, it will file a Form 8-K.
ITEM 5.02 Departure of Directors or Principal Officers;
Election of Directors
On July 1, 2014 James M. Cassidy resigned as the Registrant's president,
secretary and director.
On July 1, 2014, James McKillop resigned as the Registrant's vice
president and director.
On July 1, 2014 Dr. Sergio Calqueiro was named as the director of the
Registrant and was appointed its President and sole officer.
Dr. Sergio Calqueiro serves as the President and sole director of the
Registrant. Dr. Calqueiro has experience in business and finance as well as
medicine, energy and chemistry. From 2009-2012, Dr. Calqueiro has worked
with Alante Financial Group to set up financial structures for various projects
in Europe. His industry experience includes manufacturing, physics, cell
chemistry, finance and medical research in organ cell preparations. In 2011
Dr. Calqueiro founded High Tech Concepts Marketing which shepherded storage
system technology to provide economical storage systems for a massive amount
of electricity. His company, with which he continues to work, has become the
sales and marketing arm for Eco Energy Europe. Dr. Calqueiro holds a MBBCH
degree from the University of the Witwatersrand, Johannesburg, RSA.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunder duly authorized.
LIGHTSTONE TECHNOLOGIES INC.
Date: July 7, 2014 /s/ Dr. Sergio Calqueiro
President
